GLG News by Juvederm Users: Cosmetic Dermatologists (US)

Ceragenix's new product Epiceram, the Barrier repair cream has potential merit and efficacy comparable to mid strength topical steroids:1. Barrier repair has been found to be antiinflammatory.2. The product in mouse studies has effects comparable to steroid creams.3. The product will have less/ minimal...

Centocor's product CNTO1275 will have a major and sustained impact on the market:1. Its PASI 75 reduction is better than the current injectables other than Centocor's Infliximab, which requires a complicated IV infusion.2. Side effects are comparable to other agents.3. It is specifically being developed...

Implications: Palomar and Gillette’s venture in the direct to consumer sale of a light based laser device has several issues that will effect the ability of this venture to be successful 1. The device is only approved for non facial areas, and is only temporarily effective with less than 10% reduction-...

This lay article proves again that lawyers are actively pursuing litigation in this profitable field.  Given that over 1 million people per year have this surgery, and physicians are under constant pressure to increase patient volumes, it is a potentially dangerous combination. ...

This article describes the Phase II trial results of the PreView Scleral Implants (ReFocus Group Inc.) for the treatment of presbyopia.  Presbyopia is the natural age related loss of accommodation, or near focusing ability that leads to people wearing reading glasses. Scleral implants alter the...

AMO's acquisition of Intralase for $808 million has been seen by most financial industry analysts as positive.  Most financial analysts point to the improved diversification and strengthening of AMO's refractive portfolio which includes intraocular lenses, phacoemulsification equipment, VISX excimer...

It is reported today that AMO will purchase Intralase Corp for 808 million dollars in what could securely position AMO as the world leader in all aspects of LASIK and laser vision correction technology. For months it has been speculated that such a purchase would occur.

While the use of Intacs has practically ended for routine correction of myopia, and the company management and ownership has shifted several times in the last few years, there has been a great interest and success in using these implants for the stabilization of eyes with ectasias such as keratoconus...

This article describes the results of a "newer" refractive surgery technique known as sub-Bowman's keratomileusis or SBK.  SBK involves creating a corneal flap just below the epithelial layer of the cornea.  This flap is approximately 60-70 microns in thickness compared to a traditional...

Despite short term patient satisfaction for the correction of myopia, with the multiple problems and issues associated with the approval of the Visian ICL (phakic iol) for correction of myopia over the past several years, and some studies that indicated higher corneal endothelial cell count loss and...